English
往期目录
新闻公告
More
化学进展 2012, Vol. Issue (9): 1707-1719 前一篇   后一篇

• 综述与评论 •

抗肿瘤多核铂配合物的研究

徐刚1,2, 姜平元1,2, 苟少华*1,2   

  1. 1. 东南大学化学化工学院 南京 211189;
    2. 江苏省生物药物高技术研究重点实验室 南京 211189
  • 收稿日期:2011-11-01 修回日期:2012-06-01 出版日期:2012-09-24 发布日期:2012-09-27
  • 通讯作者: 苟少华 E-mail:sgou@seu.edu.cn
  • 基金资助:

    国家自然科学基金项目(No. 20971022和No.21271041)资助

下载PDF ( 999 ) 引用
导出 被引次数 ( 8 | 1 )

Multinuclear Anticancer Platinum Complexes

Xu Gang1,2, Jiang Pingyuan1,2, Gou Shaohua1,2   

  1. 1. School of Chemistry and Chemical Engineering, Nanjing 211189, China;
    2. Jiangsu Province Hi-Tech Key Laboratory for Bio-Medical Research, Nanjing 211189, China
  • Received:2011-11-01 Revised:2012-06-01 Online:2012-09-24 Published:2012-09-27
多核铂配合物作为非经典铂抗肿瘤药物,其抗肿瘤机制与现有铂类抗肿瘤药物不同,因而在克服现有铂类抗肿瘤药物耐药性方面有着巨大的潜力。本文综述了多核铂类抗肿瘤药物的研究进展,以连接铂原子的桥配体结构的不同,可分为六大类:以烷基二胺及其衍生物为桥的多核铂配合物、以含氮杂环为桥的多核铂配合物、以羧酸根为桥的多核铂配合物、以卤素离子为桥的多核铂配合物、以含硫配体为桥的多核铂配合物及以其他配体为桥的多核铂配合物。本文还介绍了这几类多核铂配合物的抗肿瘤机理及在克服顺铂耐药性机理方面的研究进展。
关键词： 多核铂, 抗肿瘤活性, 桥连基团, 作用机理, DNA加合物
Multinuclear platinum anticancer complexes have been investigated intensively due to their novel structures and promising anticancer activities. Moreover, they are able to overcome cisplatin resistance because of their abilities to form different adducts with DNA compared with those formed by cisplatin. The research status of dinuclear and multinuclear anticancer platinum complexes is reviewed. Based on the different linking ligands, dinuclear and multinuclear are divided to six types, namely, alkyl diamines and their derivatives, heterocyclic compounds containing nitrogen atom(s), carboxylates, haloid anions, ligands containing sulfur atom(s) and other ligands. The possible anticancer mechanism and structure-activity relationship of these multinuclear platinum complexes are also discussed in this paper. Contents 1 Introduction
2 Diamines and their derivatives as linking ligands
2.1 Flexible diamines
2.2 Polyamines
2.3 Semi-rigid diamines and polyamines
3 Heterocycles containing nitrogen atom(s) as linking ligands
3.1 Pyrazole and its derivatives
3.2 Pyrazine and its derivatives
3.3 Bipyridine and its derivatives
3.4 Pyrimidine and its derivatives
3.5 Macrocyclic polyamines
4 Haloid anions as linking ligands
5 Carboxylates as linking ligands
6 Linking ligands containing sulfur atom(s)
7 Other linking ligands
8 Conclusions and outlook
Key words: multinuclear platinum complexes, anticancer activity, linking ligand, anticancer mechanism, DNA adduct

中图分类号: 

()
[1] Rosenberg B, van Camp L, Trosko J E, Manosour V. Nature, 1969, 222(5191): 385-386
[2] Wheate N J, Walker S, Craig G E, Oun R. Dalton Trans., 2010, 39(35): 8113-8127
[3] Gibson D. Dalton Trans., 2009, 10681-10689
[4] Mangrum J B, Farrell N P. Chem. Commun., 2010, 6640-6650
[5] Ruhayel R A, Langner J S, Oke M J, Berners-Price S J, Zgani I, Farrell N P. J. Am. Chem. Soc., 2012, 134: 7135-7146
[6] Qu Y, Bloemink M J, Reedijk J, Hambley T W, Farrell N. J. Am. Chem. Soc., 1996, 118: 9307-9313
[7] Hensing T A, Hanna N H, Gillenwater H H, Gabriella C M, Allievi C, Socinski M A. Anticancer Drugs, 2006, 17: 697-704
[8] Qu Y, Fitzgerald J A, Rauter H, Farrell N. Inorg. Chem., 2001, 40: 6324-6327
[9] Ruhayel R A, Zgani I, Berners-Price S J, Farrell N P. Dalton Trans., 2011, 40: 4147-4154
[10] Tayyem H, Huq F, Yu J Q, Beale P, Fisher K. ChemMedChem, 2008, 3: 145-151
[11] Zhang J Y, Thomas D S, Berners-Price S J, Farrell N. Chem. Eur. J., 2008, 14: 6391-6405
[12] Marini V, Kasparkova J, Novakova O, Scolaro L M, Romeo R, Brabec V. J. Biol. Inorg. Chem., 2002, 7: 725-734
[13] Jansen B J, Zwan J, Dulk H, Brouwer J, Reedijk J. J. Med. Chem., 2001, 44: 245-249
[14] Kapp T, Dullin A, Gust R. J. Med. Chem., 2006, 49: 1182-1190
[15] Kapp T, Krueger M, Ott I, Steiner S, Schumacher P, Nachbaur D, Gastl G, Gust R, Kircher B. J. Inorg. Biochem., 2008, 102: 713-720
[16] Cesara E T, Almeida M V, Fontes A P S, Maia E S P, Garnier-Suillerot A, Couri M R C, Felicio E C A. J. Inorg. Biochem., 2003, 95: 297-305
[17] Kortes R A, Geib S J, Lin F T, Shepherd R E. Inorg. Chem., 1999, 38: 5045-5052
[18] Zhao Y J, Bali M S, Cullinane C, Day A I, Collins J G. Dalton Trans., 2009, 5190-5198
[19] Montero E I, Benedetti B T, Mangrum J B, Oehlsen M J, Qu Y, Farrell N P. Dalton Trans., 2007, 4938-4942
[20] Zerzankova L, Suchankova T, Vrana O, Farrell N P, Brabec V, Kasparkova J. Biochem. Pharmacol., 2010, 79: 112-121
[21] Williams J W, Qu Y, Bulluss G H, Alvorado E, Farrell N P. Inorg. Chem., 2007, 46: 5820-5822
[22] Jansen B A J, van der Zwan J, Reedijk J, den Dulk H, Brouwer J. Eur. J. Inorg. Chem., 1999, 1429-1433
[23] Zerzankova L, Kostrhunova H, Vojtiskova M, Novakova O, Suchankova T, Lin M X, Guo Z J, Kasparkova J, Brabec V. Biochem. Pharmacol., 2010, 80: 344-351
[24] Lin M X, Wang X Y, Zhu J H, Fan D M, Zhang Y M, Zhang J F, Guo Z J. Apoptosis, 2011, 16: 288-300
[25] Zhu J H, Lin M X, Fan D M, Wu Z Y, Chen Y C, Zhang J F, Lu Y, Guo Z J. Dalton Trans., 2009, 10889-10895
[26] Wang X Y, Guo Z J. Dalton Trans., 2008, 12: 1521-1532
[27] Tu C, Lin J, Shao Y, Guo Z J. Inorg. Chem., 2003, 42: 5795-5797
[28] Zhao Y M, HeW J, Shi P F, Zhu J H, Qiu L, Lin L P, Guo Z J. Dalton Trans., 2006, 2617-2619
[29] Kalayda G V, Jansen B A J, Molenaar C, Wielaard P, Tanke H J, Reedijk J. J. Biol. Inorg. Chem., 2004, 9: 414-422
[30] Kalayda G, Jansen B A J, Wielaard P, Tanke H J, Reedijk J. J. Biol. Inorg. Chem., 2005, 10: 305-315
[31] Couri M R C, Almeida M V, Fontes A P S, Chaves J D S, Cesar E T, Alves R J, Pereira-Maia E C, Garnier-Suillerot A. Eur. J. Inorg. Chem., 2006, 9: 1868-1874
[32] Komeda S, Lutz M, Spek A L, Yamanaka Y, Sato T, Chikuma M, Reedijk J. J. Am. Chem. Soc., 2002, 124: 4738-4746
[33] Komeda S, Bombard S, Perrier S, Reedijk J, Kozelka J. J. Inorg. Biochem., 2003, 96: 357-366
[34] Teletchea S, Komeda S, Teuben J M, Elizondo-Riojas M A, Reedijk J, Kozelka J. Chem. Eur. J., 2006, 12: 3741-3753
[35] Komeda S, Lin Y L, Chikuma M. ChemMedChem, 2011, 6: 987-990
[36] Uemura M, Suzuki T, Nishio K, Chikuma M, Komeda S. Metallomics, 2012, 4: 686-692
[37] Uemura M, Yoshikawa Y, Chikuma M, Komeda S. Metallomics, 2012, 4: 641-644
[38] Collins J G, Wheate N J. J. Inorg. Biochem., 2004, 98: 1578-1584
[39] Wheate N J, Evison B J, Herlt A J, Phillips D R, Collins J G. Dalton Trans., 2003, 3486-3492
[40] Kelly M E, Dietrich A, Gomez-Ruiz S, Kalinowski B, Kaluderovic G N, Muller T, Paschke R, Schmidt J, Steinborn D, Wagner C, Schmidt H. Organometallics, 2008, 27: 4917-4927
[41] Komeda S, Kalayda G V, Lutz M, Spek A L, Yamanaka Y, Sato T, Chikuma M, Reedijk J. J. Med. Chem., 2003, 46: 1210-1219
[42] Kalayda G V, Komeda S, Ikeda K, Sato T, Chikuma M, Reedijk J. Eur. J. Inorg. Chem., 2003, 4347-4355
[43] Brabec V, Christofis P, Slamova M, Kostrhunova H, Novakova O, Najajreh Y, Gibson D, Kasparkova J. Biochem. Pharmacol., 2007, 73: 1887-1900
[44] Zhao G H, Hu X S, Yu P, Lin H K. Transit. Metal Chem., 2004, 29: 607-612
[45] Chan H L, Ma D L, Yang M, Che C M. J. Biol. Inorg. Chem., 2003, 8: 761-769
[46] De Pascali S A, Migoni D, Papadia P, Romano A, Marsigliante S, Pellissier A, Chardon-Noblat S, Ciccaresea A, Fanizzi F P. Dalton Trans., 2008, 5911-5921
[47] Schilter D, Urathamakul T, Beck J L, Hardingc M M, Rendina L M. Dalton Trans., 2010, 39: 11263-11271
[48] Mounir M, Lorenzo J, Ferrer M, Prieto M J, Rossell O, Avilesand F X, Moreno V J. J. Inorg. Biochem., 2007, 101: 660-666
[49] Kodaka M, Dohta Y, Rekonen P, Okada T, Okuno H. Biophys. Chem., 1998, 75: 259-270
[50] Matsunami J, Urata H, Matsumoto K. Inorg. Chem., 1995, 34: 202-208
[51] Galindo M A, Galli S, Navarro J A R, Romero M A. Dalton Trans., 2004, 2780-2785
[52] Galindo M A, Olea D, Romero M A, Gomez J, del Castillo P, Hannon M J, Rodger A, Zamora F, Navarro J A R. Chem. Eur. J., 2007, 13: 5075-5081
[53] Lakomska I, Kooijman H, Spek A L, Shen W Z, Reedijk J. Dalton Trans., 2009, 10736-10741
[54] Gao E J, Liu L, Zhu M C, Huang Y, Guan F, Gao X N, Zhang M, Wang L, Zhang W Z, Sun Y G. Inorg. Chem., 2011, 50: 4732-4741
[55] Liang X, Parkinson J A, Parsons S, Weishäupl M, Sadler P J. Inorg. Chem., 2002, 41(17): 4539-4547
[56] Liang X, Weishäupl M, Parkinson J A, McGregor P A, Sadler P J. Chem. Eur. J., 2003, 9(19): 4709-4717
[57] Xu Z H, Zhang Y M, Xue Z Q, Yang X L, Wu Z Y, Guo Z J. Inorg. Chim. Acta, 2009, 362(7): 2347-2352
[58] Jansen B A J, Wielaard P, den Dulk H, Hrouwer J, Readijk J. Eur. J. Inorg. Chem., 2002, 9: 2375-2379
[59] Quiroga A G, Perez J M, Lopez-Solera I, Monteroa E I, Masaguera J R, Alonso C, Navarro-Ranninger C. J. Inorg. Biochem., 1998, 69(4): 275-281
[60] Zhang J C, Liu L, Gong Y Q, Zheng X M, Yang M S, Cui J R, Shen S G. Eur. J. Med. Chem., 2009, 44(5): 2322-2327
[61] Noji M, Kizu R, Takeda Y, Akiyama N, Yoshizaki I, Eriguchi M, Kidani Y. Biomed. Pharmacother., 2005, 59: 224-229
[62] Zhang J C, Li Y P, Sun J, Li W X, Gong Y Q, Zheng X M, Cui J R, Wang R Q, Wu J. Eur. J. Med. Chem., 2009, 44(11): 4772-4777
[63] Gao E J, Zhu M C, Yin H X, Liu L, Wu Q, Sun Y G. J. Inorg. Biochem., 2008, 102(10): 1958-1964
[64] Van Beek E R, Löwik C W G M, Ebetino F H, Papapoulos S E. Bone, 1998, 23: 437-442
[65] Margiotta N, Ostuni R, Gandin V, Marzano C, Piccinonnaa S, Natile G. Dalton Trans., 2009, 10904-10913
[66] Margiotta N, Capitelli F, Ostuni R, Natile G. J. Inorg. Biochem., 2008, 102: 2078-2086
[67] Margiotta N, Ostuni R, Piccinonna S, Natile G, Zanellato I, Boidi C D, Bonarrigo I, Osella D. J. Inorg. Biochem., 2011, 105: 548-557
[68] Momekov G, Ferdinandov D, Bakalova A, Zaharieva M, Konstantinov S, Karaivanova M. Arch. Toxicol., 2006, 80: 555-560
[69] Miyamoto T K, Ichida H. Bull. Chem. Soc. Jpn., 1991, 64: 1835-1839
[70] Xie M J, Liu W P, Lou L G, Chen X Z, Ye Q S, Yu Y, Chang Q W, Hou S Q. Inorg. Chem., 2010, 49: 5792-5794
[71] Gao C Z, Gou S H, Fang L, Zhao J. Bioorg. Med. Chem. Lett., 2011, 21: 1763-1766
[72] Gao C Z, Xu G, Gou S H. Bioorg. Med. Chem. Lett., 2011, 21: 6386-6388
[73] Hamers F P T, Pette C, Bravenboer B, Vecht C J, Neijt J P, Gispen W H. Cancer Chemother. Pharmacol., 1993, 32(2): 162-166
[74] Murdoch P S, Kratochwil N A, Parkinson J A, Patriarca M, Sadler P J. Angew. Chem. Int. Ed., 1999, 38(19): 2949-2951
[75] Matesanz A I, Hernandez C, Rodriguez A, Souza P. Dalton Trans., 2011, 40: 5738-5745
[76] Teles W M, Machado F C, Montanari C A, Filgueiras C A L, Jenkins T C. Transit. Metal Chem., 2005, 30: 733-737
[77] Vetter C, Kaluderovic G N, Paschke R, Gómez-Ruiz S, Steinborn D. Polyhedron, 2009, 28: 3699-3706
[78] Woodhouse S L, Ziolkowskia E J, Rendina L M. Dalton Trans., 2005, 2827-2829
[79] Messori L, Shaw J, Camalli M, Mura P, Marcon G. Inorg. Chem., 2003, 42: 6166-6168
[80] Bielawska A, Popawska B, Sura yński A, Czarnomysy R, Bielawski K. Eur. J. Pharmacol., 2010, 643: 34-41
[81] Poplawska B, Bielawska A, Sura yński A, Czarnomysy R, Bielawski K. Folia. Histochem. Cytobiol., 2009, 47(5): S141-S146
[82] Sun R W Y, Chow A L F, Li X H, Yan J J, Chui S S Y, Che C M. Chem. Sci., 2011, 2: 728-736
[83] Zhang J C, Wang L W, Xing Z Y, Liu D D, Sun J, Li X L, Zhang Y. Anticancer Agents Med. Chem., 2010, 10(4): 272-282
[1] 贾航, 乔越, 张玉, 孟庆鑫, 刘程, 蹇锡高. 玄武岩纤维增强树脂基复合材料界面改性策略[J]. 化学进展, 2020, 32(9): 1307-1315.
[2] 吴锋, 赵双义, 卢赟, 李健, 苏岳锋, 陈来. 化学结合力载体在锂硫电池中的应用[J]. 化学进展, 2017, 29(6): 593-604.
[3] 王家敏, 史蕾, 刘海洋. 咔咯及其金属配合物与DNA的作用和抗肿瘤活性[J]. 化学进展, 2015, 27(6): 755-762.
[4] 张明明, 樊建芬, 于怡, 闫希亮, 许健. 生物铵转运蛋白对NH3/NH4+作用机理研究[J]. 化学进展, 2015, 27(11): 1658-1664.
[5] 李晓佩, 黄昆, 林洁媛, 徐怡庄, 刘会洲. Hofmeister离子序列及其调控水溶液中大分子溶质行为的作用机制[J]. 化学进展, 2014, 26(08): 1285-1291.
[6] 崔建国, 刘亮, 甘春芳, 肖琦, 黄燕敏. 芳（杂）环甾体化合物的合成及生理活性研究[J]. 化学进展, 2014, 26(0203): 320-333.
[7] 田圆, 赵倩莹, 胡靖, 周辰, 缪灵, 江建军. 衬底上石墨烯制备及改性研究[J]. 化学进展, 2012, 24(04): 512-522.
[8] 黄燕敏, 崔建国, 甘春芳, 姚秋翠, 贾琳怡. 具有生理活性的甾体酰胺类化合物[J]. 化学进展, 2012, 24(01): 61-69.
[9] 张小年, 刘亚楠, 杨晓新, 刘杰. 钌配合物诱导肿瘤细胞凋亡的信号通路及其作用机制[J]. 化学进展, 2011, 23(5): 983-990.
[10] 张鹭 侯玉霞 袁会珠 覃兆海. 复合物Ⅲ抑制剂型杀菌剂——结构类型和作用机理*[J]. 化学进展, 2010, 22(09): 1852-1868.
[11] 冯峰,王超,吕美玲,汪海林. DNA加合物检测*[J]. 化学进展, 2009, 21(0203): 503-513.
[12] 柴永明,安高军,柳云骐,刘晨光. 过渡金属硫化物催化剂催化加氢作用机理*[J]. 化学进展, 2007, 19(0203): 234-242.
[13] 曲平 何华 Liu,Xuhui . 铑配合物的抗肿瘤活性及其作用机制研究[J]. 化学进展, 2006, 18(12): 1646-1651.
[14] 杨频,高飞,马贵斌. 化学核酸酶及其作用机理[J]. 化学进展, 1997, 9(03): 273-.
[15] 商振华,周良模. 膜亲和色谱的现状、发展和应用[J]. 化学进展, 1995, 7(01): 47-.
阅读次数
全文


摘要

抗肿瘤多核铂配合物的研究